Why the study?
Does the stabilized human umbilical vein provide a safe alternative for aortocoronary bypass grafts in patients lacking satisfactory saphenous veins?
Does the stabilized human umbilical vein provide a safe alternative for aortocoronary bypass grafts in patients lacking satisfactory saphenous veins?
The stabilized human umbilical vein may serve as a safe and viable alternative conduit for aortocoronary bypass in patients without suitable saphenous veins, demonstrating favorable short-term outcomes.
Should not yet change conduit selection; leaves open the role of stabilized umbilical vein grafts pending controlled trials.
Nine patients received 16 aortocoronary bypass grafts utilizing the umbil ical vein. A 4-mm internal diameter Dardik Biograft (Meadox Laboratories, Oakland, NJ) was used in all cases. Eight right coronary arteries, five circumflex, two anterior descending, and one diagonal artery were bypassed. There were no surgical deaths or perioperative myocardial infarctions. Clin ically, all patients are doing well 1 to 16 months postoperatively. Technical aspects of using these grafts are described. In patients lacking satisfactory saphenous veins, the umbilical vein can be used for the aortocoronary position. Continued long-term clinical evaluation is necessary.
No takes yet. Share an insight, caveat, or question.
Silver et al. (1980) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: